Ignite Creation Date:
2024-05-05 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00135395
Status:
COMPLETED
Last Update Posted:
2010-02-05
First Post:
2005-08-25
Brief Title:
A Phase IIIb Study Comparing Two Boosted Protease Inhibitor-based HAART Regimens in HIV-infected Patients Experiencing Their First Virologic Failure While Receiving an NNRTI-containing HAART Regimen
Sponsor:
Bristol-Myers Squibb
Organization:
Bristol-Myers Squibb